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Summary Retinoids can reverse potentially premalignant lesions and prevent second primary tumours in patients with head and neck
squamous cell carcinoma (HNSCC). Furthermore, it has been reported that acquired resistance to all-trans retinoic acid (RA) in leukaemia is
associated with decreased plasma peak levels, probably the result of enhanced retinoid metabolism. The aim of this study was to investigate
the metabolism of retinoids and relate this to growth inhibition in HNSCC. Three HNSCC cell lines were selected on the basis of a large
variation in the all-trans RA-induced growth inhibition. Cells were exposed to 9.5 nm (radioactive) for 4 and 24 h, and to 1 and 10 gM (non-
radioactive) all-trans RA for 4, 24, 48 and 72 h, and medium and cells were analysed for retinoid metabolites. At all concentrations studied,
the amount of growth inhibition was proportional to the extent at which all-trans-, 13- and 9-cis RA disappeared from the medium as well as
from the cells. This turnover process coincided with the formation of a group of as yet unidentified polar retinoid metabolites. The level of
mRNA of cellular RA-binding protein 11 (CRABP-11), involved in retinoid homeostasis, was inversely proportional to growth inhibition. These
findings indicate that for HNSCC retinoid metabolism may be associated with growth inhibition.
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Retinoids are a class of compounds that consists of the natural
vitamin A derivatives, such as retinol, retinal, retinoic acid (RA)
and their various metabolic products, and the synthetic derivatives
that are structurally related to these natural compounds (Dawson
and Hobbs, 1994). Natural retinoids are important for normal
epithelial cell differentiation. A low vitamin A (retinol) plasma
level and a low dietary intake ofretinoids have been proven to be
risk factors in various carcinomas (Hong and Itri, 1994). Many
studies report inhibiting effects of exogenous retinoids on the
induction and progression of cancer in various tissues (Lotan,
1993). As for solid tumours, retinoids are particularly important
for head and neck squamous cell carcinoma (HNSCC) (Benner et
al, 1993). Three retinoids, 13-cis retinoic acid (13-cis RA) (Hong
et al, 1986), retinyl palmitate (Stich et al, 1988) and all-trans
retinoic acid (all-trans RA) (Koch, 1978), cause responses in
40-70% ofpatients with leucoplakia, the most common premalig-
nant lesion ofthe mucosa ofthe oral cavity (Van der Waal, 1992).
It has also been demonstrated that administration of 13-cis RA
could successfully prevent and/or delay the occurrence of second
primary tumours in the upper aerodigestive tract (Hong et al,
1990). In a chemotherapeutic approach, single-agent 13-cis RA
has limited activity in advanced squamous cell carcinoma of the
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head and neck (Linnman et al, 1988). Thus far, retinoids appear to
be active in early-stage HNSCC, but their utility is limited by the
interpatient variability with respect to not only response, but also
to side-effects. Anothercharacteristic oftreatmentofHNSCC with
retinoids is that discontinuation of treatment leads invariably to
recurrence ofthe lesion (Hong and Itri, 1994).
It is not known how retinoids are actually able to regulate
growth control. The association between vitamin A deficiency
and the development of cancer suggests that the intracellular
retinoid-dependent pathways play a role in cancer development.
Most ofthe actions ofretinoids are thought to result from changes
in gene expression mediated by nuclear retinoic acid receptors
(RARs) and retinoid X receptors (RXRs) (Mangelsdorf et al,
1994). Retinoids bind to these receptors, which act as transcription
factors upon dimerization. The expression of one such RAR-3, as
determined by in situ hybridization was found to be selectively
absent in 31 of52 leucoplakiacases and could be restored by treat-
mentwith 13-cis RA (Lotan et al, 1995). Restoration ofexpression
is associated with a clinical response to 13-cis RA. However,
pretreatment levels ofRAR-P do not predict the clinical response
(Lotan et al, 1995). Sixty-five percent ofclinical HNSCC samples
show a lack ofRAR-, expression, as judged by in situ hybridiza-
tion (Xu et al, 1994). No association, however, was found in
HNSCC cell lines between all-trans RA sensitivity and the expres-
sion of RARs, RXRs and the cellular retinoic acid-binding
proteins (CRABP) (Zou et al, 1994).
All-trans RA induces complete remission in most patients with
acute promyelocytic leukaemia. However, relapses are frequent
and resistance to the drug is developing. This resistance is associ-
ated with unexpectedly low plasma levels of retinoids despite
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continued treatment (Muindi et al, 1994). The interindividual vari-
ation in retinoid pharmacokinetics is already known from other
studies (Eckhoffet al, 1991; Adamson etal, 1993; Lee etal, 1993),
and it is hypothesized that the variability in the pharmacokinetics
of all-trans RA may result from differences in catabolic rates
determined or influenced by genetic or environmental factors.
Thus, a poor metabolism may be associated with a response,
whereas enhanced retinoid metabolism is associated with acquired
therapy resistance (Muindi et al, 1994). CRABP-II levels may be
the cause ofthis resistance, as increased levels ofthis enzyme have
been found in tumour cells from relapsed patients treated with all-
trans RA (Delva et al, 1993). Also, the oxidative breakdown via
the cytochrome P450 enzyme system is a possible explanation
(Rigas et al, 1993). Two lines ofevidence for the latter possibility
have been provided: a tenfold increase in the 4-oxo-all-trans RA
glucuronide has been found in the urine of relapsed patients
(Muindi et al, 1994) and ketoconazole and liarozole, inhibitors of
the cytochrome P450 system, are able to attenuate this catabolism
(Wouters et al, 1992; Rigas et al, 1993).
In vitro, variation in growth inhibition after exposure of
HNSCC to all-trans RA has been reported (Jetten et al, 1990;
Sacks et al, 1995), and thus far this variation cannot be explained
(Zou et al, 1994). The aim ofthis study was to investigate the pres-
ence or absence of a variation in retinoid metabolism between
HNSCC cell lines and whether this is related to the degree of
growth inhibition by all-trans RA.
MATERIALS AND METHODS
Cell lines
HNSCC cell lines were obtained from Dr TE Carey, University of
Michigan, Ann Arbor, MI, USA, and are described elsewhere
(Carey, 1985). UM-SCC-14C originated from a local recurrence of
cancer of the floor of the mouth, UM-SCC-22A and -35 from
hypopharyngeal tumours. Cells were cultured routinely in DMEM
(Dulbecco's modified Eagle medium, ICN Biomedicals, Irvine,
UK) with 5% fetal calf serum (FCS, Flow Laboratories) in 75-cm2
flasks (Nunc, Roskilde, Denmark). Cellular doubling times were
26 h for UM-SCC-14C, 52 h for UM-SCC-35 and 34 h for the
UM-SCC-22A cell line.
Chemicals
All-trans RA was obtained from Acros Chimica (Geel, Belgium),
4-oxo-trans- and cis-RA were kind gifts of Hoffmann-la Roche,
Basle, Switzerland; retinol and 13-cis-RA were obtained from
Sigma (St Louis, MO, USA). All compounds were dissolved as a
10-2 M stock in dimethylsulphoxide (DMSO, JT Baker, Deventer,
The Netherlands) and stored at -80°C. For each experiment
freshly prepared solutions were made, the first (10-3 M) being
made with DMSO. Subsequent dilutions were prepared in cell
culture medium. All handling with retinoids was performed in
subdued light, tubes were wrapped in aluminium foil and oxida-
tion was prevented by replacing the air by nitrogen.
Cell growth inhibition studies
Effects on the growth of HNSCC cells were determined using the
'SRB assay'. Details of the assay, which measures the cellular
protein content, reflecting the actual cell number, have been
described previously (Braakhuis et al, 1993). In short, cells were
plated at a concentration of 1500 (UM-SCC-14C), 2000 (UM-
SCC-22A) and 3000 (UM-SCC-35) cells per well in 150 gl of
DMEM and 5% FCS, and were allowed to attach and grow for
72 h (the 'lag phase'). After this phase, it was found that control
(incubated only with culture medium) cell growth was logarithmic
for a period up to 96 h. Consequently, all-trans RA was added in
50 ,gl of medium, resulting in a final concentration that varied
between 10-5 and 10-9 M. Growth was assessed after 72 h (the 'log
phase'), by staining the cellular protein with sulphorhodamine B
(SRB, Sigma) and spectrophotometric measurement ofthe absorp-
tion at 540 nm with a microplate reader. IC50 values were esti-
mated based on the absorption values and defined as the
concentration that corresponded to a reduction in growth of 50%
compared with values for untreated control cells. When using the
highest concentration of all-trans RA, a 1% DMSO solution was
present in the cell culture medium. Control experiments showed
that exposing the cells to this level ofDMSO without all-trans RA
leads to a growth inhibition ofbetween 10% and 25%.
In a separate set of experiments the effect of conditioned
medium was tested on the growth rate of UM-SCC-14C and -35
cells. For this purpose flasks containing near-confluent UM-SCC-
35- and -14C-cells were exposed to 10- and 10-8 M all-trans RA
for 24 h. These conditioned media were added to cells growing in
96-well plates that were about to start their log phase. The cells
were exposed to this conditioned medium for another 72 h and the
level of growth inhibition was determined by the 'SRB assay', as
described.
Exposure to radioactive all-trans RA
Near-confluent cultures, growing under normal conditions, were
treated for4 and 24 h with 9.5 nM [1,12-3H] all-trans RA (Dupont
NEN Research Products, Dordrecht, The Netherlands, sp. act.
52.1 Ci mmol-1). After incubation the medium was removed and
saved at -80°C. Cells were rinsed with phosphate-buffered
saline (pH 7.4, PBS), scraped in 1 ml of PBS and collected by
centrifugation. Cell pellets were stored at -80°C until extraction.
Retinoids were extracted and analysed by reversed-phase high-
performance liquid chromatography (HPLC) as described previ-
ously (Pijnappel et al, 1993). The following standards were
included: 13- and 9-cis- and all-trans RA. The experiment was
performed in duplicate.
Exposure to non-radioactive all-trans RA
Cells were cultured to near confluence in 75-cm2 flasks with 5 ml
of medium (DMEM plus FCS). The cells were exposed to 10 and
1 gM all-trans RA. At each time point (0, 4, 24, 48 and 72 h) 500 tl
of the supematant was taken from a separate flask and stored at
-80°C in the darkuntil analysis. Forthe analysis ofthe intracellular
concentration ofretinoids, the flasks were washed twice with fresh
PBS (pH 7.4) and the cells were trypsinized. The number of living
cells (determined with trypan blue) was calculated and cell pellets
were washed twice with PBS and stored at-80°C in the dark.
Non-radioactive retinoids were determined by reversed-phase
HPLC after extraction with acetonitrile (Teerlink et al, 1997). A
Waters (Milford, MA, USA) HPLC system was used, consisting of
a model 717 plus automatic sample injector, a model 616 gradient
pump, a model 486 UV detector, and a temperature control module
and column heater. Mobile phase was degassed online using a
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model DG2410 degasser from Uniflows (Tokyo, Japan).
Millennium 2010 software from Waters was used for instrument
control and data acquisition. Separation was performed on a
Spherisorb ODS2 3-im column (100 x 4.6 mm) from Phase
Separations (Deeside, UK) maintained at 30°C. Composition of
the mobile phases and the binary gradient used were as described
by Eckhoff and Nau (1990). UV detection was performed at
340 nm and retinoids were identified using external standardiza-
tion. We included the following standards: 4-oxo-trans RA, 4-oxo-
cis RA, 13-cis RA, all-trans RA and retinol. As we also intended
to measure the levels ofunknown retinoid metabolites, the results
were expressed as a percentage ofthe total area under the curve of
the relevant part of the chromatogram (retention time between 6
and 30 min).
Measurement of CRABP mRNA levels
Total RNA was isolated from cultured cells according to Gough
(1988). Total RNA (20 jg) was loaded on a 1% agarose
formaldehyde gel and electrophoresed in 3-(N-morpholine)-
propane sulphonic acid (MOPS) buffer essentially as described by
Sambrook et al (1989). The RNA was Northern blotted by capil-
lary transfer in 10 x saline sodium citrate (SSC) (Sambrook et al,
1989) onto genescreen plus filters (Dupont NEN). The filter was
baked for 2 h at 80°C, prehybridized in 7% sodium dodecyl
sulphate (SDS), 0.5 M sodium phosphate buffer, 2 mm EDTA,
pH 7.0, for 2 h at 65°C, and after addition ofthe denatured probe,
hybridized at 65°C for 16 h. The probes were made by labelling
the isolated 0.6-kb XbaV/BamHI fragment containing human
CRABP-I cDNA (Astrom et al, 1991), the 1-kb EcoRI fragment
containing human CRABP-II cDNA (Astrom et al, 1991) and the
0.2-kb fragment containing part of 18S rRNA cDNA with
[a-32P]dCTP to a specific activity of approximately 109 dpm jig-
by multiprimed elongation (Feinberg and Vogelstein, 1983). After
hybridization the filters were washed twice with 2 x SSC, 0.2%
SDS and twice with 0.2 x SSC, 0.2% SDS, at 65°C for 15 min, and
the bands visualized by autoradiography with Kodak X-AR 5 film
using intensifying screens. 18S rRNA was used as an internal
standard to correct for the amount ofRNA loaded on the gel.
RESULTS
Inhibition of cell proliferation
The three HNSCC cell lines were selected for their considerable
difference intheirresponse to all-trans RA (Figure IA). UM-SCC-35
was the most sensitive line with an IC50 value of 6.8 nm. UM-SCC-
14C showed hardly any response, even after exposure to the rela-
tively high concentration of 10-5 M. The third line, UM-SCC-22A,
showed an intermediate type of response, with a moderate growth
inhibition at the broad concentration range from 10-5 to 10-9 M.
Metabolism of 9.5 nM[3H]all-trans RA
The fate of [3H]all-trans RA was studied in the media and the cell
pellets ofall three cell lines. The cells were exposed to 9.5 nm all-
trans RA, a concentration that is in the range found in human
plasma (Eckhoff et al, 1991). The concentration of [3H]all-trans
RA decreased in the medium and the time dependency of this
effect differed between the cell lines (Figure 2). In UM-SCC-35
this decrease started at 4 h and led to a total loss at 24 h exposure
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Figure 1 The SRB test was used to assess the antiproliferative effect of all-
trans RA in three HNSCC cell lines (A). Li, UM-SCC-14C; 0, UM-SCC-22A;
A, UM-SCC-35. The growth inhibiting effect of 4-trans-oxo RA on two
HNSCC cell lines is shown in B. Results of three separate experiments are
indicated (means ± s.d.)
(Figure 2G and H). A similar decrease was seen for 9- and 13-cis
RA. For this cell line the contribution of all-trans RA to the total
amount ofretinoids was relatively low, being 22% at 4 h and 1.4%
at 24 h. For the insensitive line, UM-SCC-14C, the concentration
ofall-trans RA in the medium was the highest (19.5%) of all three
cell lines at 24 h (Figure 2C and D) and for the UM-SCC-22A a
somewhat lower value (9.4%) was observed (Figure 2E and F).
The HPLC method of analysis enabled us to measure retinoid
metabolites. In the media of the cell cultures a number of peaks
could be detected after 4 and 24 h exposure to [3H]all-trans RA,
corresponding to retention times between 2 and 20 min (Figure 2).
ForUM-SCC-35 these peaks formed at 24 h the majority (86 %) of
the total of labelled retinoids. These polar metabolites were less
prevalent in the two other cell lines, being 49% and 68% for UM-
SCC-14 and 22A respectively.
As the intracellular recovery was rather low, varying between
0.2% and 2.5% of the total amount of radioactivity added, only
estimations ofretinoid levels could be made. Intracellular retinoid
levels decreased in the course oftime. UM-SCC-35 had the lowest
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Figure 2 High-performance liquid chromatogram after 4 (left) and 24 h (right) exposure to 9.5 nM [3H]all-trans RA. Results are expressed in c.p.m. on the y-axis
after multiplication by 10-3. Note the difference in disappearance of retinoids and formation of metabolites between the cell lines. Data are shown for the culture
media. We included the following standards with the corresponding retention times in minutes: 13-cis-RA (24.3), 9-cis-RA (25.5), all-trans-RA (26.2). (A and B)
Medium without cells; (C and D) UM-SCC-14C; (E and F) UM-SCC-22A; and (G and H) UM-SCC-35. This experiment was performed in duplicate. A
representative experiment is shown
levels ofintracellular retinoids, most ofthem being polar metabo- Metabolism of 1 and 10 ,UM unlabelled all-trans RA
lites. The differences between the lines, however, were not as large
as seen in the media.
The observed decrease in retinoid levels in the cell culture
media is mainly due to retinoid turnover by the cells. Without cells
the decrease in retinoid levels in the medium was minimal (Figure
2 A and B).
When exposed to 1 gM all-trans RA, retinoid metabolites were
measured after various time points (Figure 3 and Table 1). In
general, the pattern is similar to that seen with the exposure to the
lower concentration, but the effect was less dramatic. Because
now the exposure time is longer, the kinetics of disappearance of
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Figure 3 Measurement of retinoids in cell culture media after various periods of exposure to 1 0--6m all-trans RA. (A) values are expressed as a percentage
of the total area under the curve of the relevant part of the chromatogram (retention time between 6 and 30 min, see Figure 4); T= 0 has been set at 1O00%.
B, values are expressed as a percentage of the total area under the curve of the total chromatogram at that given time point
0.010
0.008
D 0.006
0.003
0.001 . _
-0.001
5 10 15 20
Retention time (min)
Figure 4 HPLC chromatogram of the cell culture medium
24 h after exposure to 10-6 M all-trans RA. Peaks: 1, all-trn
RA; 3, 13-cis RA; 4, retinol; 5, 4-oxo-13-cis RA. Note the L
between 6 and 21 min. AU, arbitrary units
the retinoids can be studied in more detail. The
the major retinoids from the medium was high
SCC-35 cell line. After 24 h this is already ver
reaches an apparent plateau at 48 h with 10% of t
The disappearance of retinoids from the other
more gradual, UM-SCC-14C being the slowest
regard to the composition of the retinoids a
observed: the contribution of the unidentifiable p
visible as a number ofpeaks with retention times 1
min, actually increased. These metabolites coulc
all three cell lines, but was most remarkable f
followed in order by UM-SCC-22A and -14C.
high-performance liquid chromatogram of UM-S
exposure is given in Figure 4.
After exposure to I ltM all-trans RA, UM-.
lowest and UM-SCC-22A the highest levels
retinoids. The intracellular concentrations were
considered accurate. Generally speaking, retinoid
in the course oftime, but no polar metabolites cot
When the cells ofthe three cell lines were expo
trans RA, the pattern seen was similar to that wit
sure experiments (data not shown).
Growth inhibition by retinoid metabolites
We wished to investigate whether growth inhibition in the UM-
SCC-35 cell line could be caused by the excessive formation of one
4 or more toxic retinoid metabolites. To test this hypothesis we
performed two types ofexperiments. Two cell lines were exposed to
a well-known polar metabolite of all-trans RA, 4-oxo-trans RA.
This compound was found to induce growth inhibition in the UM-
25 30 SCC-35 cell line (Figure 1B), although to a lesser extent than
all-trans RA, IC50 values being 39.0 and 6.8 nm respectively (Figure
of UM-SCC-35, IA). This metabolite was not active in the UM-SCC-14C cell line.
ns RA; 2, 9-cis In a second set ofexperiments we argued that UM-SCC-35 cells
unidentified peaks might produce toxic metabolites and that these were released into
the medium. Thus, UM-SCC-35 cells were exposed for 24 h to
10-6 and 10-1 M all-trans RA and it was found that this medium,
disappearance of when added to virgin UM-SCC-14C cells, minimally affected
lest for the UM- growth of these cells (Figure 4). Incubation of UM-SCC-35 cells
y significant and with conditioned medium of UM-SCC-14C cells (after treatment
-he original level, with 10-8 M), however, caused a stronger antiproliferative effect
two cell lines is than incubation with the medium derived from UM-SCC-35 cell
(Figure 3). With cultures. It appears that newly formed retinoids are less potent with
shift could be respect to growth inhibition than the parent compounds they were
olar metabolites, derived from, but it must be added that, on an individual basis, the
between 6 and 21 concentration of these metabolites is significantly lower than the
I be detected for concentration of parent retinoid (Table 1).
Anr exaMpleCof Measurement of CRABP expression ,An example of
CC-35 after 24 h CRABP-I and -II are proteins involved in retinoid homeostasis and
they may be important with respect to metabolism and growth
SCC-35 had the inhibition. We therefore analysed CRABP-I and -II expression by
of intracellular Northern blotting and hybridization. CRABP-I had undetectable
too low to be transcript levels in all cell lines, confirming previous results (Zou
levels decreased et al, 1994). The analysis of CRABP-II showed that UM-SCC-35
uld be detected. had considerably lower transcript levels than the other two cell
)sed to 10 JM all- lines (Figure 5). Exposure to 10-6 M all-trans RA for 24 h had an
th the 1 ,UM expo- apparent down-regulating effect on CRABP-II mRNA levels in
UM-SCC-14C and -22A.
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Figure 5 The results of the effects of conditioned media are expressed as a percentage of the control (untreated) cellular growth. Cells grown in culture flasks
were exposed for 24 h with 10-8 M (-) or 106 M (0) all-trans RA to provide the conditioned medium [derived from UM-SCC-14C (A) and UM-SCC-35 (B)]. The
conditioned medium was added to cell cultures set up in 96-well plates and after a period of 72 h exposure the proliferation rate of the cells was measured. Cell
growth was measured with the SRB-assay (see Materials and methods). The mean of two experiments with SD is shown. For the sake of clarity the UM-SCC-
prefixes in the designations of the cell lines were omitted
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Figure 6 mRNA expression of CRABP-11 was determined with Northern blot
in three HNSCC cell lines. Cells were untreated (-) or treated with 10- M all-
trans-RA (+) for 24 h. 18S rRNA was used as a reference to correct for the
amount of RNA loaded on the gel. For the sake of clarity the UM-SCC-
prefixes in the designations of the cell lines were omitted
DISCUSSION
In this study of three HNSCC cell lines, it was shown that the
extent ofall-trans RA-induced growth inhibition is proportional to
a decrease in retinoid levels in cells and the corresponding culture
medium. In the culture medium without cells, which was taken as
a control, the extent of retinoid disappearance was minimal,
leading to the interpretation that the removal of retinoids from the
medium is a cell-mediated process. This disappearance of
retinoids coincided with the production of retinoid metabolites,
detectable in the medium. Thus, the major finding of this study is
that the extent of metabolism is proportional to the degree of
growth suppression. This suggests that retinoid metabolism is
associated with growth inhibition. Interestingly, this relation has
also been found for breast carcinoma cell lines (Takatsuka et al,
1996; BM van der Leede et al, manuscript in preparation).
It has been reported that, in a proportion of patients treated
continuously for leukaemia with all-trans RA, some have lower
blood plasma retinoid levels at 28 days than during the first cycles
oftreatment (Muindi et al, 1992). This lowering ofretinoid plasma
levels is proposed to be the result of an induced metabolism that
eventually leads to the development oftherapy resistance (Martini
and Murray, 1993). Thus, hypothetically, two phenotypes of
'rapid' and 'slow catabolizers' can be discriminated in the popula-
tion of leukaemia patients (Rigas et al, 1993). Our present data,
however, indicate that the ability of HNSCC cells to metabolize is
related not to resistance, but rather to a growth-inhibitory effect.
This paradox may be explained by the fact that various cell types
could differ in retinoid requirement, turnover and induction of
growth inhibition, as has been shown for the first two aspects to be
the case for a variety of tissue types (Kurlandsky et al, 1995).
Membrane transport is most likely not an important variable in
explaining a difference in growth inhibition. Retinol and retinoic
acid are preferably bound to proteins and passive diffusion most
likely determines cellular uptake (Blaner and Olson, 1994).
Differences in uptake between the cell lines that have been studied
in the present report, however, cannot be excluded, and a 63-kDa
receptor, recently described to be involved in retinol uptake (Bavik
et al, 1993), may be involved in this process.
An important question that remains to be answered is whether
metabolism is the cause or the consequence ofgrowth modulation.
First, the hypothesis can be formulated that intracellular turnover
of retinoids is the driving force causing growth inhibition. In case
of sensitivity, as soon as retinoic acid enters the cell in either the
cis or the trans form, it is very efficiently metabolized to one or
more cytotoxic polarcompounds. In the most sensitive line studied
here, turnover is very efficient; at the physiological concentration
of 9.5 nm the majority of the original concentration of all
detectable retinoids has disappeared from the medium after 24 h.
The remainder of the labelled compound may have become too
polar to be detected with the currently used eluent. In the culture
medium of this sensitive cell line the majority of the detectable
British Joumal of Cancer (1997) 76(2), 189-197
194 BJM Braakhuis et al
A
150 r
100 -
e
CO
50 I
0
35
. Cancer Research Campaign 1997Retinoids in headand neck cancer 195
Table 1 HPLC-analysis of cell culture medium after exposure to 106M all-trans retinoic acid
Cell line Exposure Recoverya All-trans RAa 13-cis RAa 9-cis RAa,b Retinola 4-oxo-cis-RAa Polar Remainderad
time (h) metabolitesac
None 0 100 89.4 + 3.1 5.1 + 1.8 1.8 + 0.8 2.6+ 1.2 u.d.l. 0.1 + 0.2 u.d.1.
4 105.7 + 8.1 93.6 + 8.8 6.2 + 2.5 2.1 + 0.8 2.3+ 1.1 u.d.l. 0.2 + 0.5 1.0+ 1.2
24 106.7 + 4.7 91.7 + 7.2 8.4 + 2.4 2.8+ 0.9 2.3+ 1.1 u.d.l. 0.1 + 0.3 1.3+ 1.3
48 108.3 + 5.6 90.7 + 6.7 10.7 + 1.5 3.5 + 0.6 2.0+ 0.9 u.d.l. 0.1 + 0.3 1.4 + 1.4
72 110.9+ 11.4 88.1 + 11.5 14.4+ 1.8 4.8 + 0.7 1.7 + 0.5 u.d.l. 0.1 + 0.2 1.2+ 1.3
UM-SCC-14C 0 100 90.8 + 0.6 4.7 + 0.3 1.5 + 0.6 2.2 + 0.4 u.d.l. 0.3+ 0.4 0.5+ 0.7
4 119.6 + 42.2 106.3 + 39.0 6.9 ± 0.3 1.9+ 0.1 2.7+ 1.1 u.d.l. 0.8+ 1.2 1.0 + 0.8
24 109.5 + 52.7 93.5+ 49.1 9.3 + 1.4 2.6+ 0.3 0.7+ 1.0 0.6+ 0.4 1.9 + 1.2 1.6 + 0.2
48 95.6+0.1 76.3+3.7 11.7+1.7 3.5+1.1 0.5+0.3 0.4+0.1 1.9+0.8 1.0+1.5
72 81.8 + 7.5 55.1 + 1.5 13.2 + 5.5 4.5 + 2.4 0.6+ 0.1 1.1 + 0.9 5.8+ 2.2 2.6 + 0.3
UM-SCC-22A 0 100 88.2 +4.2 6.1 + 2.2 1.9 + 1.2 1.7+ 0.8 u.d.l. u.d.l. 2.1 + 1.0
4 94.5 + 12.9 81.5 + 10.3 7.0 + 1.9 1.9 + 0.6 1.4 + 0.3 u.d.l. u.d.l. 2.7 + 0.4
24 67.6 ± 18.3 54.3+ 15.1 6.7 + 2.4 1.8 + 0.7 0.8+ 0.2 0.2 + 0.2 2.4+ 0.4 1.7 + 0.5
48 54.5 + 49.5 37.0 + 35.7 7.4 + 8.4 2.3 + 2.4 0.5 + 0.3 0.9 + 0.9 5.8 + 2.5 1.5 + 1.8
72 29.4 + 26.7 16.9 + 19.3 4.5 + 4.2 1.6 ± 1.5 0.3+ 0.2 0.8+ 0.7 5.1 + 2.0 1.0 + 1.0
UM-SCC-35 0 100 90.2 + 1.5 4.6 + 1.4 1.6 + 0.5 2.8 + 2.0 u.d.l. u.d.l. 0.7 + 0.8
4 93.7 + 21.0 82.2 + 17.6 4.7+ 3.1 1.6 + 0.6 2.4 + 1.5 0.4 + 0.5 1.8 + 1.1 1.0 + 0.7
24 29.8 + 18.9 10.0 + 8.0 2.0+ 1.9 0.5 + 0.5 2.3 + 0.8 0.6 + 0.8 12.8 + 7.5 2.1 + 2.9
48 10.6+6.2 0.9+0.9 0.4+0.4 0.1 ±0.1 2.0+0.9 0.6+0.7 5.7+3.6 1.5+1.9.
72 9.0+9.1 0.2+0.4 u.d.l. u.d.l. 2.0+0.6 0.3+0.2 4.2+5.1 2.5+3.0
Cell culture media were analysed with HPLC after exposure for various times (mean of three separate experiments + s.d. is shown). aValues are expressed as a
percentage of the total area under the curve of the relevant part of the chromatogram (retention time between 6 and 30 min, see Figure 4). T= 0 has been set
at 100%. bA peak was observed between all-trans RA and 13-cis RA and based on literature data this peak was identified to represent 9-cis RA. cThis refers to
compounds identified by peaks with a retention time between 6 and 21 min (see Figure 4). aThis refers to compounds identified by peaks with a retention time
between 21 and 30 min, with the exception of the known retinoids, 13-, 9-cis, all-trans RA and retinol. u.d.l., under detection limit.
retinoids are present in the form of 'polar metabolites'. It is
conceivable that a sensitive cell line has a relatively high expres-
sion of the enzymes involved in metabolism, for example oxida-
tive enzymes such as the cytochrome P450s (Martini and Murray,
1993; Rigas et al, 1993). The question arises whether unidentified
metabolites also have growth-inhibitory activity. Although it has
been reported that the 4-oxo-retinoic acid derivatives are consid-
ered breakdown products in humans (Eckhoff et al, 1991), these
molecules have also a transcription-activating capacity (Pijnappel
et al, 1993). In addition, 4-oxo derivation of retinal to 4-oxoreti-
naldehyde and the subsequent conversion to 4-oxoretinoic acid
and 4-oxoretinol is suggested to be an important step during
Xenopus embryogenesis (Blumberg et al, 1996). That study also
showed that all these 4-oxo products were able to bind to and
transactivate RARs. Our results also show that oxo derivatives
have growth-inhibiting capacity (Figure IB). The experiments
with conditioned medium provided no evidence that the sensitive
UM-SCC-35 cells produced a 'suicide' retinoid. The lack ofeffect
ofthe conditioned medium to produce growth inhibition, however,
could be attributed to the fact that the levels of the specific
metabolite were too low, perhaps because of further degradation.
The peaks corresponding to the levels of the known 4-oxo-oxida-
tion products were rather low.
A second hypothesis can be formulated on the relationship
between growth inhibition and metabolism. Retinoid metabolism is
a secondary event and is an attempt by the cell to neutralize the
growth-inhibiting effect. In this scenario, all-trans RA and/or 13-cis
RA are the key retinoids that cause growth inhibition and the other
metabolites must be considered as breakdown products. This
hypothesis is further supported by the notion that conditioned
medium of the insensitive cell line containing high levels of all-
trans- and 13-cis RA appeared to be still very growth inhibitory for
the UM-SCC-35 cells. In addition, the expression of CRABP-II
mRNA is in further favour of this hypothesis. It has been suggested
that CRABP forms an intracellular buffer if the RA concentration
exceeds a certain level (Astrom et al, 1991; Adamson et al, 1993;
Bavik et al, 1993; Delva et al, 1993; Griffiths et al, 1993; Blaner and
Olson, 1994; Napoli et al, 1995). The present study supports this
theory, as the most sensitive cell line was found to have the lowest
levels ofCRABP-II, and the addition of more RA failed to increase
its synthesis. In contrast, Zou et al (1994) reported that CRABP-II
expression was not related to retinoid sensitivity in four HNSCC
cell lines. An argument against the relation between high CRABP-II
levels and insensitivity is the fact that all-tranis treatment does not
up- but rather down-regulates CRABP-II mRNA expression. This
phenomenon has already been observed for other epithelial cell
lines (Sanquer et al, 1993; Zou et al, 1994). The data, taken together,
suggest that CRABP expression can be important but that no
general rule can be formulated. Further studies should elucidate the
importance of these molecules, and the possibility that the amount
ofprotein is more important than the level oftranscription cannot be
excluded. The positive correlation between a CRABP expression
and metabolism as has been found for CRABP-I in F9 teratocarci-
noma stem cells (Boylan and Gudas, 1992) is in contrast with the
currently reported results. The differences in the types of cells and
the function ofthese proteins may explain this discrepancy.
The levels of retinol in the medium of UM-SCC-35 cells remain
high during the course of the exposure and deserve special attention.
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The relatively low consumption ofretinol from the medium ofUM-
SCC-35 suggests that the cells are not able to use retinol as a retinoid
source to produce retinoic acid. A low activity of one or more
enzymes of the group of alcohol dehydrogenases, involved in the
conversion ofretinol to retinoic acid, may be responsible for such an
effect (Harding and Duester, 1992; Napoli et al, 1995). As a conse-
quence the cells may have adapted themselves to low intracellular
levels of all-tranis RA. Theoretically, any excess of all-trans RA is
not adequately buffered and may lead to cell death. This concept is in
agreement with the hypothesis that metabolism is a secondary event.
One can only speculate about the mechanism responsible for
retinoid induced growth inhibition. Studies on leucoplakia by
Lotan et al (1995) suggest that the induction of expression of
RAR-3 is important for growth suppression. The same group,
however, could not find such a correlation when studying malig-
nant HNSCC cell lines (Xu et al, 1994). We have also found no
indication that the expression per se or induction by retinoic acid
of RAR-o and -y, and RXR-ix is related to sensitivity of the cell
lines used (Copper et al, 1997). RAR-f mRNA levels were too low
to be measured. A recent in vitro study on breast cancer cells
showed that RAR-a antagonists were as efficient in inhibiting
growth as agonists (Dawson et al, 1995). This indicates that
binding of a retinoid to a RAR may be important but that tran-
scriptional activation on a retinoic acid-responsive element
(RARE) is not a prerequisite. It is not clear whether this finding
can be extrapolated to the in vivo situation and whether it can be
extended to other tumour types. No indications are available that
RAR-u. is important in growth inhibition ofHNSCC.
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